Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

METRONIDAZOLE 375 MG CAPSULE

Metronidazole
$7.3080per EA
High Outlier

Strength

375 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135083650

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

1/21/2026

Active Ingredients

METRONIDAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA076522

On Market Since

1/29/2004

Pharmacological Classes

Nitroimidazole Antimicrobial
Nitroimidazoles

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-6.0%

1Y

-8.3%

3Y

N/A

5Y

N/A

All

+13.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

METRONIDAZOLE 250 MG TABLET
Generic
00904715661•Major Pharmaceuticals
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065101•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065105•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
58657093301•Method Pharmaceuticals LLC
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
58657093305•Method Pharmaceuticals LLC
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
69292020750•Amici Pharma, Inc
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
72578000701•Viona Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
72578000705•Viona Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
72578000721•Viona Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 500 MG TABLET
Generic
00904712661•Major Pharmaceuticals
$0.1022
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy